PACLX
Price
$35.41
Change
+$0.19 (+0.54%)
Updated
Jun 6 closing price
Net Assets
66B
RBAIX
Price
$27.59
Change
+$0.08 (+0.29%)
Updated
Jun 6 closing price
Net Assets
4.73B
Interact to see
Advertisement

PACLX vs RBAIX

Header iconPACLX vs RBAIX Comparison
Open Charts PACLX vs RBAIXBanner chart's image
T. Rowe Price Capital Appreciation Adv
Price$35.41
Change+$0.19 (+0.54%)
VolumeN/A
Net Assets66B
T. Rowe Price Balanced I
Price$27.59
Change+$0.08 (+0.29%)
VolumeN/A
Net Assets4.73B
PACLX vs RBAIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PACLX vs. RBAIX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACLX is a StrongBuy and RBAIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PACLX has more cash in the bank: 66B vs. RBAIX (4.73B). RBAIX pays higher dividends than PACLX: RBAIX (2.15) vs PACLX (1.87). PACLX was incepted earlier than RBAIX: PACLX (20 years) vs RBAIX (9 years). PACLX (1.00) is less costly to investors than RBAIX (0.52). PACLX is a more actively managed with annual turnover of: 85.00 vs. RBAIX (39.20). PACLX has a lower initial minimum investment than RBAIX: PACLX (2500) vs RBAIX (500000). RBAIX annual gain was more profitable for investors over the last year : 3.84 vs. PACLX (1.51). RBAIX return over 5 years is better than : 21.34 vs. PACLX (16.95).
PACLXRBAIXPACLX / RBAIX
Total Expense Ratio0.970.47206%
Annual Report Gross Expense Ratio1.000.52192%
Fund Existence20 years9 years-
Gain YTD3.4675.23766%
Front LoadN/AN/A-
Min. Initial Investment25005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets66B4.73B1,397%
Annual Yield % from dividends1.872.1587%
Returns for 1 year1.513.8439%
Returns for 3 years10.8018.7558%
Returns for 5 years16.9521.3479%
Returns for 10 years48.01N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USAGX30.29N/A
N/A
Victory Precious Metals and Minerals
LOGSX20.56N/A
N/A
Live Oak Health Sciences
SCGSX126.38N/A
N/A
DWS Capital Growth S
RSVYX25.58N/A
N/A
Victory RS Value Y
ACETX10.53N/A
N/A
Invesco Equity and Income Y